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Mitochondrial coupling efﬁciency is pivotal in thermogenesis and energy homeostasis. Here we
show that deletion of cyclophilin D (CypD), a key modulator of the mitochondrial permeability tran-
sition pore, demonstrated resistance to diet-induced obesity (DIO) in both male and female mice,
due to increased basal metabolic rate, heat production, total energy expenditure and expenditure
of fat energy, despite increased food consumption. Absorption of fatty acids is not altered between
CypD/ and wild-type mice. Adult CypD/ developed hyperglycemia, insulin resistance and glucose
intolerance albeit resistant to DIO. These data demonstrate that inhibition of CypD function could
protect from HFD-IO by increasing energy expenditure in both male and female mice. Inhibition
of CypD may offer a novel target to modulate metabolism.
 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
When dietary energy is maintained at a constant level, weight
gain or loss depends on the energy expenditure through exercise
and other obligatory bodily functions and on the coupling efﬁ-
ciency. Coupling efﬁciency is deﬁned as the proportion of the cal-
ories burned and oxygen consumed that is coupled to ATP
synthesis. One of the mechanisms by which metabolic efﬁciency
can be lowered is to activate futile cycles of ATP synthesis and
hydrolysis. Proton leaks have been reported to account for 26% of
resting energy expenditure in isolated hepatocytes and up to 50%
in perfused rat skeletal muscle [1]. Although the mechanism for
the proton leak is not deﬁned, the adenine nucleotide translocase
(ANT), involved in export of ATP from mitochondria, is implicated
[2]. In addition, oxidative phosphorylation is uncoupled by induc-
ible proton leak in specialized tissues such as brown fat by uncou-
pling proteins (UCPs) to cause adaptive thermogenesis.
Obesity is associated with diminished brown fat activity [3] and
it was proposed that a malfunction of the brown-fat-speciﬁc
uncoupling by UCP-1 may explain this phenomenon. Interestingly,
UCP-1 gene deletion, although lacked the ability to respond tochemical Societies. Published by E
; HF, high fat; RQ, respiratory
n pore
r and Integrative Physiology,
-5850, United States. Fax: +1
ilam).
777 Old Saw Mill River Road,b-adrenergic stimulated thermogenesis during acclimation to cold
[4], they failed to demonstrate an obese phenotype [5,6]. However,
a recent report demonstrated that at thermoneutrality, the meta-
bolic efﬁciency was increased in UCP-1 deﬁcient mice and they
had an obesogenic phenotype [7], rekindling the role for UCP1 in
bioenergetics.
Another possible mechanism by which leakage of protons may
occur is by the intermittent opening of mitochondrial permeability
transition pore (MPTP). MPTP opening allows small molecules be-
low the size of 1500 Da to pass through the inner mitochondrial
membrane causing disruption of the transmembrane potential
and proton gradient [8]. Cyclophilin D (CypD) is a critical compo-
nent of the PTP that can modulate the permeability of the channel
in response to various stress stimuli [9]. A role for MPTP in diet-in-
duced obesity has not been investigated. We hypothesized that
modulation of MPTP by CypD could be an alternate mechanism
by which energy metabolism is uncoupled and adaptive thermo-
genesis could occur. To test, we fed HFD to CypD deﬁcient mice
and determined the effect of CypD deﬁciency on body weight, food
intake, energy expenditure, body fat stores and glucose tolerance.
2. Results
2.1. CypD deﬁcient mice are resistant to high fat diet-induced obesity
In order to determine the effect of CypD deﬁciency on energy
homeostasis, we fed 6 week-old male and female cypD/ mice
along with age and genetically matched wild-type (WT)
(B6129SF2/J) mice with either high fat (HF; 45% fat by calories,lsevier B.V. All rights reserved.
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period of 19 weeks. The body weight of mice from different groups
was similar at the beginning of the study. Mice from all groupswere
weighedweekly and quantitative data demonstrated that the rate at
which body weight increased was signiﬁcantly lower in HF fed
CypD/ male (Fig. 1A) and female (Fig. 1B) mice compared to their
WT counterparts. CypD/ mice appeared smaller in size compared
to their WT counterparts at 17 weeks post-HF diet and a represen-
tative photograph of the male animals is shown (Supplementary
Fig. S1A). These results demonstrate that both male and female
cypD/ mice are resistant to HF diet-induced obesity.
To understand the mechanism by which CypD deﬁciency
protects against obesity, the body weight and fat mass, food intake,
metabolic level and energy expenditure were measured in CypD/
and WT mice. At 19 weeks post-HF feeding, the difference in body
weight between cypD/ and WT male mice was 34.6% (n = 4;
P < 0.01) and female mice was 38.4% (Fig. 1C-top panel). No differ-
ence in body weight between control diet fed WT and CypD/
mice was noted up to 19 weeks post-feeding. Analysis of the body
composition of cypD/ and WT male mice fed HF, using quantita-
tive nuclear magnetic resonance (NMR) method, at the 19 week
study’s completion time point revealed that CypD/ mice haveFig. 1. (A) Average body weights of WT and CypD/ male mice: (⁄P < 0.001; n = 6–8) com
⁄P < 0.001 (n = 6–8) compared to WT high-fat fed female mice. (C-top panel) The averag
panel) The percentage of fat mass (⁄P < 0.01), lean mass (P > 0.05) and water mass (⁄P < 0
NMR method (n = 4 per group).signiﬁcantly lower percentage of fat mass (P < 0.01; n = 4),
increased water content (P < 0.01; n = 4) but no change in the per-
centage of lean mass compared to WT mice (Fig. 1C-bottom panel).
2.2. Food consumption is decreased in female but not in male cypD/
mice
Measurement of food intake in HF-fed CypD/ and WT male
mice demonstrated that the cumulative food intake over a period
of 17 weeks adjusted for body mass demonstrated a signiﬁcant in-
crease in both male and female CypD/ mice (Fig. 2A and B,
respectively). However, the average feed consumption in absolute
mass and kilocalories are comparable during the HF feeding period
in male CypD/ andWTmice but signiﬁcantly decreased in female
CypD/ mice on HF diet compared to their WT counterparts (Sup-
plementary Fig. S2A and S2B). The cumulative feed efﬁciency (in-
crease in body weight relative to energy intake), determined as
previously described [10] was also signiﬁcantly decreased in both
male and female CypD/ mice compared to their WT counterparts
(Supplementary Fig. S2C). These data suggest that the decrease in
body weight in CypD/ male mice is independent of feed intake,
and despite similar levels of feed consumption, CypD/ male micepared to WT high-fat diet fed male mice. (B) Average body weight of female mice:
e body weight of WT and CypD/ male mice fed HF-diet for 19 weeks. (C-bottom
.01) in WT and CypD/ male mice fed HF-diet for 19 weeks were analyzed by the
Fig. 2. (A) Cumulative energy intake adjusted for body mass in WT and CypD/ male mice on HF diet for 17 weeks: ⁄P < 0.05 compared to WT mice on high-fat diet (n = 8).
(B) Cumulative energy intake adjusted for body mass in WT and CypD/ female mice on HF diet for 17 weeks: ⁄P < 0.05 compared to WT mice on high-fat diet (n = 8).
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possibly by uncoupling of respiration.
2.3. Food reabsorption is not altered in CypD-KO mice
In order to determine if the difference in fat absorption efﬁ-
ciency between WT and CypD-KO mice was due to a difference
in fat reabsorption, fecal lipid output was measured directly after
they were fed the HF diet for 18 weeks. The percentage of palmi-
tate (16:0) in the fecal sample was 34.86 ± 2.358 and
27.14 ± 3.470 (P > 0.05; n = 4) in CypD-KO and WT mice, respec-
tively. The percentage of stearate (18:0) in the fecal sample was
56.59 ± 4.488 and 50.22 ± 4.081 (P > 0.05; n = 4) in WT and CypD-
KO mice, respectively. The percentage of oleate (18:1) in the fecal
sample was 11.86 ± 4.488 and 12.75 ± 4.081 (P > 0.05; n = 4) in WT
and CypD-KO mice, respectively. These data demonstrate that
there are no signiﬁcant changes in absorption of the fat content
as the fecal content of fat was not altered between the groups
and thus, the decreased obesity in CypD-KO mice may not due to
an alteration in the fecal lipid output when maintained on a
high-fat diet. Collectively, these data suggest that the resistance
to DIO observed in HF-fed CypD/ mice is not due to hypophagia
or an alteration in the fecal lipid output.
2.4. Decreased body weight in cypD/ mice is partly due to increased
energy expenditure
Indirect calorimetry experiments were carried out to investi-
gate whether the resistance to weight gain in CypD/ mice is
due to increased energy expenditure. CypD/ mice maintained
on HF diet for 19 weeks were placed in the indirect calorimeter
for 24 h with unlimited access to HF diet and water. CypD/ mice
consistently had an increase in metabolic rate as demonstrated by
an increase in oxygen consumption compared to WT mice
(61.93 ± 0.35 in CypD/ versus 49.39 l/kg of body weight of VO2
in WT mice) (Fig. 3A) as well as an increase in CO2 produced
(Fig. S3A). The respiratory quotient (RQ) of 0.82 measured during
the active period (dark cycle) in CypD/ mice indicates that these
mice used fatty acids as the main energy source while a RQ of 0.89
in WT mice indicated the use of more carbohydrates than fat as
their energy source (Fig. 3B). Thus the effect of CypD deﬁciency
on decreasing body weight and fat mass may be inﬂuenced by
the decreased RQ and increase in fat oxidation. This notion is fur-
ther supported by our observation that levels of circulating triglyc-
erides and free-fatty acids were similar in both genotypes,
suggesting that in CypD/ mice, triglycerides were being rapidly
oxidized in energy-consuming tissues. Further, analysis of the bodycomposition of cypD/ and WT male mice fed HF, using NMR also
revealed that CypD/ mice have signiﬁcantly lower percentage of
fat mass (see above). Heat (cal/h/kg) was measured for 24 h in
cypD/ and wt mice during the 24 h period (Fig. 3C) and was
18 144 cal/kg/h and 14 572 cal/kg/h, respectively. The mean en-
ergy expenditure (EE) was calculated separately during both light
and dark cycles. CypD/ mice demonstrated increased energy
expenditure during both cycles.
2.5. Body temperature
The body temperature of WT and CypD/ mice was measured
using a rectal probe. Heat production (cal/h/kg) is a measure of
caloric output and is directly proportional to metabolic rate. Both
WT and CypD/ male mice displayed the expected diurnal rhythm
with increased heat production during the dark period (P < 0.05).
Consistent with increase in EE, female CypD/ mice had higher
core body temperature (38.58 ± 0.54) compared to WT mice
(38.025 ± 0.44; n = 4; P = 0.181) while male CypD/ mice had core
body temperature of (38.158 ± 0.54) compared to WT mice
(37.58 ± 0.44; n = 4). The increase in body temperature of female
KO mice were more prominent, a ﬁnding consistent with their
complete resistance to weight gain post-HF feeding. The higher
core body temperature found in CypD/ mice suggests that ther-
mogenic mechanisms to be more active in these mice to maintain
homeothermy.
2.6. Normal glucose levels in cypD/ mice during HF feeding
Glucose levels were monitored in CypD/ mice and WTmice at
several time points post-HF feeding. In both WT and CypD/ mice,
the levels increased gradually but were not different during the
19 week period that we studied.
2.7. Lack of insulin sensitivity and impaired glucose tolerance in
CypD/ HF-fed mice
In order to determine if there are any alterations in glucose
homeostasis in CypD/ mice, we performed an intraperitoneal
glucose tolerance test (IPGTT). WT mice and CypD/ mice that
were fed HF-diet for 19 weeks, were fasted for 5 h followed by
intraperitoneal injection with 20% D-glucose. Tail blood was
collected for measurement of glucose and insulin. Intriguingly,
CypD/ mice had decreased ability for glucose clearance as the
serum glucose levels were signiﬁcantly higher over a 120 min
period. Serum glucose levels were elevated at 15 min and reached
even higher levels at later time points. The average values of
Fig. 3. (A) Comparison of the oxygen consumption for a period of 24 h for WT and CypD/ mice that were fed HF diet for 19 weeks. Darkened bar area represents dark cycle.
(B) Comparison of the respiration quotient for a period of 24 h for WT and CypD/ mice that were fed HF diet for 19 weeks. (C) Comparison of heat dissipation by indirect
calorimetry of WT and CypD/ mice that were fed HF diet for 19 weeks.
Fig. 4. (A) Comparison of glucose tolerance by IPGTT between WT and PARP-KO male mice at 19 weeks post-HF feeding: Blood glucose levels. ⁄P < 0.05, n = 4. (B) Comparison
of glucose tolerance between WT and PARP-KO male mice: plasma insulin levels. ⁄P < 0.05, n = 4. (C) Comparison of insulin tolerance by insulin tolerance test (IST) between
WT and CypD-KOmale mice at 19 weeks post-HF feeding: blood glucose levels. ⁄P < 0.05, n = 4. (D) Comparison of insulin tolerance by insulin tolerance test (IST) betweenWT
and CypD-KO male mice at 19 weeks post-HF feeding: plasma insulin levels. ⁄P < 0.05, n = 4.
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CypD/ mice were 182, 402, 478, 487 and 370 at 0, 15, 30, 60
and 120 min post-glucose administration (Fig. 4A). In a separate
IPGTT test, insulin measurements were performed over the
120 min post-glucose administration period. Interestingly, the
plasma insulin levels were signiﬁcantly lower in CypD/ mice
0.392, 0.484, 0.348, 0.455 and 0.739 ng/ml in relation to WT mice
0.696, 0.875, 0.0.724, 0.0.817 and 0.973 ng/ml at 0, 15, 30, 60
and 120 min post-glucose administration (Fig. 4B). The decrease
in insulin levels observed in CypD/ mice, compared to WT mice
at 19 weeks post-HF feeding suggests that insulin production,
secretion, its maturation process may be impaired or alternatively,
its degradation process may be accelerated in CypD/ mice.
The ability of insulin to acutely moderate the levels of glucose
or its clearance was assessed by performing insulin tolerance test
(IST). At 19 weeks post-HF feeding, the ability of insulin to acutelystimulate glucose disposal in CypD/ mice was signiﬁcantly
blunted throughout the 60 min period monitored suggesting
decreased insulin sensitivity or insulin availability (Fig. 4C). The
level of glucose was 278 mg/dl in CypD/ mice compared to 129
in WT mice (P < 0.05; n = 4 per group) at the 60 min time point
post-insulin administration. The amount of serum insulin post
IST test shows that the level of insulin in CypD/ mice is lower
compared to that in WT mice at 0, 15, 30 and 45 min time periods
post-insulin administration (Fig. 4D). This data suggests that insu-
lin may be removed from circulation at a higher pace in CypD/
mice compared to that in WT mice.
3. Discussion
The major factor that could contribute to the decreased body
weight after high calorie intake is the imbalance in energy intake
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fed CypD/ mice have similar feed intake, feed efﬁciencies and
gross energetic efﬁciencies compared to their WT sex-matched
counterparts. These data suggest that CypD/ mice waste more
of the consumed energy and store less into body energy stores than
WT mice. Our data also demonstrate that there are no signiﬁcant
changes in absorption of the fat content as the fecal content of
fat was not altered between the groups. Taken together, these ﬁnd-
ings suggest that an increased energy output in CypD/ male mice
contributes to their resistance to the obesity phenotype.
Concurring with the decreased weight gain observed in HF
fed CypD/ mice, CypD deﬁciency increased the oxygen con-
sumption (VO2), as well as the CO2 produced (VCO2) throughout
the 24 h time period that we measured. The alterations in VO2
and in VCO2 resulted in a decreased RQ of 0.76 compared to
0.82 in WT mice. Because about 90% of mammalian VO2 is mito-
chondrial [1], increased VO2 levels expressed per gram seen in
CypD/ mice are a direct reﬂection of increased mitochondrial
oxidative metabolism. The RQ and VO2 data from this experi-
ment show that fat is more relied upon as mitochondrial fuel
substrate in CypD/ animals than in their WT controls. Thus
the effect of CypD deﬁciency on decreasing body weight and
fat mass may be inﬂuenced by the RQ, the increase in fat oxida-
tion and physical activity.
In this study, we show that HF-fed CypD/ mice compared to
their WT counterparts had increased energy expenditure (EE). EE
derives from thermogenesis resulting from cellular metabolic pro-
cesses, including basal metabolism, adaptive thermogenesis and
physical activity. Basal metabolism represents the heat production
of the body in a thermoneutral environment, under resting condi-
tions [1]. Our core body temperature measurements indicate that
the basal metabolism is increased in HF-fed CypD/ male and fe-
male mice, consistent with an increase in total EE and increased
oxygen consumption. The higher core body temperature found in
CypD/ mice suggests that thermogenic mechanisms to be more
active in these mice to maintain homeothermy. Because there is
a signiﬁcant energy cost attached to maintenance of body temper-
ature [12], this may partially account for the increased metabolism
seen in CypD/ mice. Heat production (cal/h/kg) is a measure of
caloric output and is directly proportional to metabolic rate. Both
WT and CypD/ male mice displayed the expected diurnal rhythm
with increased heat production during the dark period (P < 0.05).
Heat production per animal was increased in CypD/ male mice
compared to WT mice over a 24 h time period.
Adaptive thermogenesis is the process by which energy is dis-
sipated in the form of heat in response to environmental
changes such as exposure to cold and alterations in diet [11].
Under homeostatic conditions, adaptive thermogenesis is a key
mechanism by which body maintains core temperature and reg-
ulates energy expenditure and its dysregulation promotes obes-
ity [13]. Exposure of CypD/ male and female mice did not
result in signiﬁcant changes in their core body temperature over
a 6 h time period.
It is well established that central melanocortin systemmediated
regulation of thermogenesis is dependent on output from the sym-
pathetic nervous system (SNS) to brown fat tissue via b-adrenergic
receptors [14] and cAMP [15]. Several lines of evidence also demon-
strate that agonists and antagonists of the centralmelanocortin sys-
tem results in simultaneous activation of the SNS, brown adipose
tissue (BAT) thermogenesis and uncoupling protein 1 (UCP-1) sug-
gesting regulation of thermogenesis through a SNS-BAT-UCP-1 axis
(reviewed in [13]). It remains to be delineated whether CypD deﬁ-
ciency has any effect on the SNS or in the expression and/or func-
tion of uncoupling proteins and in catabolic pathways that may
result in reduced energy dissipation in brown fat tissue.An important question that is raised from the results of the
study pertains to the association between CypD and insulin resis-
tance in the setting of high calorie intake in adult mice. Insulin
resistance following high fat diet may involve multiple target or-
gans including adipose tissue, liver, skeletal muscle and interac-
tions among these three organs linking to neurogenic
mechanisms [16] and/or circulating factors [17]. While increased
fatty acid beta-oxidation may lower cytoplasmic lipid accumula-
tion, increasing fatty acid beta-oxidation can decrease muscle glu-
cose metabolism, and incomplete fatty acid oxidation has the
potential to also contribute to insulin resistance [18]. The effect
of CypD inhibitors on HFD-IO has not been addressed in this study.
It will be of interest to determine if the global deletion of cypD that
existed during the development may have inﬂuenced the develop-
ment of glucose intolerance and insulin resistance after HFD in the
adult CypD/ mice. Pharmacological inhibition of CypD in the set-
ting of HFD-IO may determine if its transient inhibition have sim-
ilar inﬂuence on glucose intolerance and insulin resistance and
thus efﬁcacy of CypD inhibition in treating and preventing obesity
and its metabolic consequences.
To conclude, our data indicate that CypD deﬁciency prevents
diet-induced obesity by increasing energy expenditure suggest-
ing that CypD play a central role in mitochondrial bioenergetics
and development of obesity. Identiﬁcation of molecular mecha-
nisms by which CypD deﬁciency prevented obesity may provide
potential new therapeutic opportunities to treat obesity. Devel-
oping treatment approaches to inactivate CypD function may
be a promising strategy to treat patients suffering from this
pathological disorder.
4. Materials and methods
4.1. Animal care and feeding studies
Breeding pairs of CypD/ mice were purchased from Jackson
Laboratories, Maine. CypD/ mice are viable, fertile, normal in size
and do not display any gross physical or behavioral abnormalities.
The respective WT control mice for CypD/ mice (B6129SF2/J)
were purchased from Jackson Laboratories. Thirty-ﬁve- to forty-
day-old male and female mice were maintained on a 12-h light/
dark cycle with free access to access to either a control-diet (10%
fat by calories, 3.85 kcal/g), or a HF diet (45% fat by calories,
4.76 kcal/g, Research diets Inc.). Food intake and body weight were
measured weekly. All Animal studies and procedures were ap-
proved by the institutional animal care and usage committee.
4.2. Body composition analysis by NMR method
At the end of the long-term feeding study (19 weeks on the HF
diet), the body composition of CypD/ and WT mice was analyzed
with a commercial nuclear magnetic resonance machine (Echo-
MRI-100; Echo Medical Systems). Body fat and lean tissue were
measured during the test.
4.3. Energy expenditure
On the same group of animals indicated above, oxygen con-
sumption and carbon dioxide production is measured using an
indirect calorimeter (AccuScan Instruments Inc.) Constant airﬂow
(0.75 l/min) was drawn through the chamber and monitored by a
mass-sensitive ﬂowmeter. Variables provided by this measure-
ment include VO2, VCO2, RQ, and HEAT [19]. To calculate oxygen
consumption (VO2), carbon dioxide production (VCO2), and RQ (ra-
tio of VCO2 to VO2), gas concentrations were monitored at the inlet
and outlet of the sealed chambers.
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Body temperatures were measured using a rectal digital ther-
mometer probe (model 4600; Yellow Springs Instruments, Yellow
Springs, OH).
4.5. Measurement of blood glucose
Blood was collected from fasted (12 h) mice at various time
points and different assays were performed as indicated. Blood glu-
cose was assayed with a glucometer (Hemocue glucose 201
analyzer).
4.6. Intraperitoneal glucose tolerance test (IPGTT)
At the end of the long-term feeding study (19 weeks on the
HF diet), 5 h fasted mice were injected intraperitoneally with
D-glucose (30% solution; 2 mg/g of body weight), and blood glu-
cose values were determined at 0, 15, 30, 60 and 120 min post-
injection. Baseline and test samples were all obtained from the
tail vein [19].
4.7. Insulin tolerance tests (ITT)
ITT were performed on the same group of animals 10 days after
the IPGTT test. Mice were fasted for 5 h and blood was collected for
baseline glucose values. Animals were injected intraperitoneally
with 0.5 mU/g insulin (100 mU/ml solution), and blood glucose
values were determined at 0, 15, 30 and 60 min post-injection.
4.8. Statistical analysis
Data from long-term body weight studies and ITT and IPGTT
were analyzed by two-way analysis of variance (ANOVA) with re-
peated measures. For comparisons of body composition measures,
food intake (kcal), mean kcal/h, fasting plasma glucose, a Student’s
t-test was utilized. P values less than 0.05 were considered statis-
tically signiﬁcant. All values are presented as means ± S.E.M. unless
otherwise speciﬁed.
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